Hsu TW

Department of Psychiatry, E-DA Dachang Hospital, I-Shou University, Kaohsiung, Taiwan.

7 papers

ArticlePsychedelics

Blinding Integrity and Psychedelic Drug Trials.

Hsu TW, Liang CS, Tu YK

Europe PMC2026
ArticleKetamine

Prescribing bias and adverse outcomes of esketamine in major depression comorbid substance.

Li DJ, Hsu TW, Changchien TC +4

Europe PMC2026
ArticleKetamine

Association of Esketamine use with mortality and clinical outcomes in patients with cancer-related depression: A target trial emulation.

Chen JP, Hsu CW, Fang YY +4

Europe PMC2026
ArticleKetamine

Comparison of rTMS and esketamine for treatment-resistant depression: A target trial emulation.

Chen JP, Hsu CW, Chen YT +6

Europe PMC2026
ArticlePsilocybin

The association between study design and antidepressant effects in psychedelic-assisted therapy: A meta-analysis.

Li JR, Chiang KT, Kao YC +4

Europe PMC2025
ArticlePsilocybin

Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.

Hsu TW, Tsai CK, Kao YC +8

Europe PMC2024
ArticlePsilocybin

The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis.

Chen MH, Cheng SL, Kao YC +7

Europe PMC2024